News about our portfolio and insights from the vc world
Launch of the first venture fund dedicated to diabetes technology
Diabetes is one of the most common diseases of our time and a key driver for the increase in healthcare expenditures in the years to come. The market for diabetes care devices alone is expected to reach over $40 billion by 2025.
Serpentine Rookie Fund I in a nutshell
The Serpentine Rookie Fund I (“Rookie Fund”) could be described as “founders fund” or “super-angel fund”. We accelerate top founder teams at the earliest stage when they need it most. How? With a convertible loan investment, our network, and support of our passionate team.
Serpentine Ventures invested in Cleveron - Carbon reduction Swiss-made
Cleveron is a smart solution to optimize energy use, reduce CO2 emissions and control air quality. The CHF 1.4 m Pre-Series A Round was co-led by Zentrum für Innovation und Digitalisierung Bernapark (“ZID”) and Serpentine Ventures, with the participation from 5 existing investors and 6 additional new individual investors.